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C BY-NC-Abstract Two decades of domination of benzotriazole-based chemistry stimulated the progress in
peptide synthesis to a high level of effectiveness. However, the growing need for new and more com-
plex peptide structures, particularly for biomedical studies and, very recently, for the large-scale
production of peptides as drugs, required manufacturing peptide products by efﬁcient synthetic
strategies, at reasonably low prices. Therefore, the search for new, more versatile and low-cost
reagents becomes a great challenge. Several comprehensive review articles summarized the great
effort undertaken, but up to now, no versatile coupling reagent useful for both amide and ester
bond formation, as well as for solution and solid-phase peptide synthesis has been yet developed.
The most-widely used coupling reagents are carbodiimides on one hand and phosphonium and
aminium salts on the other. Herein in this review article, we summarized the recent development
in peptide coupling reagents during the last two decades.
ª 2011 King Saud University. Production and hosting by Elsevier B.V.Open access under CC BY-NC-ND licen(T.I. Al-Warhi).
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The synthesis of proteins has challenged chemists for over a
century. Among many methodologies used or currently being
used, chemical synthesis offers attractive advantages over the
molecular biology and genetic engineering approaches.
Chemical synthesis conﬁrms the covalent structure and pro-
vides material both for three-dimensional structure determi-
nation by NMR or X-ray crystallography and for
biological evaluation. The synthesis of analogues allows the
relation between molecular structure and pharmacological
activity to be determined, and in favorable cases, compounds
with activity, selectivity, or biostability superior to the origi-
nal natural product could be produced on an industrial scale
if desired (Lloyd-Williams et al., 1997). Since the difference
between peptides and proteins is essentially one of size or
of the length of the amino acid backbone, the problems in-
volved in the chemical synthesis of proteins are basically
those of the synthesis of peptides.
Since the ﬁrst simple peptides were synthesized by The-
odor Curtius and Emil Fisher a century ago, research in
the methodology of peptide synthesis has undergone dra-
matic development. However, it is only over the last few
decades, especially after Bruce Merriﬁeld’s invention of so-
lid-phase peptide synthesis (SPPS) (Merriﬁeld, 1963) that
reliable methods for the preparation of the peptide have
been achieved. Modern synthetic methods, whether manual
or machine-assisted, using solid supports or in solution, al-
low many peptides to be synthesized without undue difﬁ-
culty. However, long peptides and proteins, or those
peptides having a high incidence of the more sensitive amino
acids, still present difﬁculties. Side reactions can always oc-
cur even in quite simple sequences, but for larger molecules
much more serious complications can manifest themselves.
In solid-phase synthesis, incomplete deprotections and cou-
pling reactions tend to become more pronounced as theO
NH2
R1O
O
NHR2
Coup
HO
RR
Scheme 1 Peptidelength of the peptide chain increases, the protocols routinely
used on an automatic multiple peptide solid-phase synthe-
sizer take advantage of potent coupling reagents and a large
excess of the acylating mixture. On the other hand, it is
well-known that over activation may lead to undesired side
reactions. Moreover, the high cost of some protected amino
acids (particularly the un-natural ones) and coupling re-
agents suggests maintaining their consumption to a reason-
ably low level, compatibly with the success of the
synthesis. In automatic multiple solid-phase synthesis, used
to obtain simultaneously peptides not only of different se-
quences but also of different length, the coupling reagents
should be efﬁcient in terms of yield and preservation of opti-
cal purity of the ﬁnal products. In particular, the coupling
reagents should be applied repetitively under standard condi-
tions to a wide range of substrates including less reactive
and sterically hindered amino acids. In addition, using an
automatic multiple peptide synthesizer, coupling reagents,
preferably commercially available and easy-to-use, should
have the following characteristics: fast reactions at room
temperature, good solubility in the common solvents, and
stability of their solutions for several days.
Synthesis in solution is only rarely a practical alternative
for large peptides, since it is slow, labor-intensive, and dogged
by the problems of racemization and poor solubility of the syn-
thetic intermediates.
2. Chemistry
2.1. Peptide bond formation
Success in the chemical synthesis of peptides, as well as peptide
libraries, relies on an efﬁcient combination of protecting
groups and coupling reagents (Scheme 1).
The formation of a peptide bond between two amino acids
involves two steps. The ﬁrst step is the activation of theling Reagent
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Recent development in peptide coupling reagents 99carboxyl group of one residue; this step accounts for a key step
in the synthesis of a large number of bioorganic molecules, in
particular during peptide synthesis (Sheehan and Hess, 1955).
If the activation of carboxylic acid is slow, the coupling re-
agents will be degraded and will no longer be able to activate
the carboxyl function. This is crucial for cyclization steps or in
convergent strategies during the fragment coupling steps be-
cause yields tend to be lower than those of other couplings
(El-Faham and Albericio, 2008).
The second step is the nucleophilic attack of the amino
group of the other amino acid derivative at the active carbox-
ylic group (Albericio and Carpino, 1997; Albericio et al., 1998,
2001; Albericio and Kates, 2000; Han and Kim, 2004; Benoi-
ton, 2006; El-Faham et al., 2006). This process is an energy-
requiring reaction (Bodanszky, 1993), therefore, one of the
carboxylic groups must be activated before the reaction can
occur. Unfortunately, this activation step, along with the next
coupling reaction, brings up a loss of conﬁguration at the car-
boxyl residue undergoing the activation process.
Peptides are, therefore, assembled by amide bond forma-
tion between optically active monomers. This being so, the
possibility of loss of chiral integrity must be considered, and
understanding the mechanisms of racemization is surely neces-
sary for its prevention. Two major pathways for the loss of
conﬁguration, both base-catalyzed, have been recognized: (a)
direct enolization, and (b) 5(4H)-oxazolone formation
(Scheme 2) (Antonovics and Young, 1967; Carpino, 1988;
Bodanszky, 1993; Lloyd-Williams et al., 1997).
As shown in Scheme 2, the controlled formation of a pep-
tide bond (the so-called ‘‘coupling’’ reaction) between two
amino acids requires activation of the carboxyl group of
one for facile reaction with the amino group of the other.
The process of activation is that aspect of peptide synthesis,which has been most extensively developed, in recent years
(Albericio and Carpino, 1997; Humphrey and Chamberlin,
1997; Lloyd-Williams et al., 1997; Albericio and Kates,
2000; Albericio et al., 2001; Han and Kim, 2004; Benoiton,
2006).
An essential feature of all coupling methods is that in addi-
tion to giving peptide bonds in good yield, the conﬁgurational
integrity of the carboxylic component must be maintained.
This duality, good yield and absence of racemization is often
difﬁcult to achieve, since usually the best methods involve con-
version of the acid to a derivative bearing a good leaving
group. Such leaving groups tend to increase the acidity of
the a-proton and favor formation of an oxazolone, as shown
in Scheme 2. Loss of conﬁguration is especially prominent if
oxazolone formation occurs, but also can occur at stages of
the activated carboxyl derivatives.
In stepwise solid-phase peptide synthesis (Merriﬁeld, 1985)
the problem of racemization is less dramatic than that for
other strategies. Several parameters have been used to deal
with such side reactions during peptide-coupling reactions. A
key issue is Na-protecting group of the amino acid to be cou-
pled (the one with the carboxylic function activated) is nor-
mally a urethane function such as, t-butoxycarbonyl (Boc, 1)
(McKay and Albertson, 1957), 9-ﬂuorenylmethyloxycarbonyl
(Fmoc, 2) (Carpino, 1987) or the recent type of base-sensitive
amino protecting groups 1,1-dioxobenzo[b]thiophene-2-ylm-
ethyloxy-carbonyl (Bsmoc, 3) (Carpino et al., 1997, 1999), 2-
(tert-butylsulfonyl)-2-propyloxycarbonyl (Bspoc, 4) (Carpino
and Philbin, 1999), 2-methylsulfonyl-3-phenyl-1-prop-2-enyl-
oxycarbonyl (Mspoc, 5) (Carpino and Mansour, 1999), 2,7-
di-tert-butyl-9-ﬂuorenylmethyloxycarbonyl (Dtb-Fmoc, 6)
(Stigers et al., 2000), and 2,7-bis(trimethylsilyl)-9-ﬂuorenylm-
ethyloxycarbonyl (Bts-Fmoc, 7) (Carpino and Wu, 2000).
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100 T.I. Al-Warhi et al.The presence of an electron withdrawing group (R0 =O-al-
kyl, Scheme 2) in these carbamates reduces the tendency to
give the oxazolone (Romoff and Goodman, 1997). Further-
more, Fmoc (2), Bsmoc (3), Bspoc (4), and Mspoc (5) can be
deblocked with a lower concentration of piperidine or weaker
bases (e.g. morpholine), thus minimizing base-catalyzed side
reactions (Carpino et al., 1997, 1999).
2.2. Coupling reagents and activation
Two decades of domination of benzotriazole-based chemistry
stimulated the progress in peptide synthesis to a high level of
effectiveness. However, the growing need for new and more
complex peptide structures, particularly for biomedical studies
and, very recently, for the large-scale production of peptides as
drugs, required manufacturing peptide products by efﬁcient
synthetic strategies, at reasonably low prices. Therefore, the
search for new, more versatile and low-cost reagents becomes
a great challenge. Several comprehensive review articles
(Albericio et al., 2001; Mizhiritskii and Shpernat, 2002; Naj-
era, 2002; Patchornik, 2002; Basso and Wrubl, 2003; Bray,
2003; Eggen, 2003; Keller and Schauwecker, 2003; Kent,
2003; Marder and Albericio, 2003; Pittman, 2003; Stachelhaus,
2003; Zhang, 2003; Han and Kim, 2004) summarized the great
effort undertaken, but up to now, no versatile coupling reagent
useful for both amide and ester bond formation, as well as for
solution and solid-phase peptide synthesis has been yet devel-
oped (Jastrza˛bek et al., 2007).
An important feature of the solid-phase approaches is the
use of large excesses of reagents. The coupling reactions are
generally faster in SPPS than in solution, thus minimizing loss
of conﬁguration. Although it is widely accepted that for step-
wise SPPS the risk of racemization is practically nil, this is not
completely true and the possibility of loss of conﬁguration
should always be kept in mind, especially for the amino acids
which are sensitive, such as cysteine or histidine.
Among the vast number of coupling methods, there are two
main classes of reagents. These involve (a) those that require
in situ activation of the carboxylic acid, and (b) those that de-
pend on the activated species that have previously been pre-R-N=C=N-R X-O-P
NR2
NR2
Y X-O
NR2
NR2
Y
Carbodiimide Phosphonium salts Aminium salts
Figure 1 Coupling reagents.pared, isolated, and characterized (Albericio and Carpino,
1997; Humphrey and Chamberlin, 1997; Kamin´ski, 2000;
Albericio et al., 2001; Han and Kim, 2004; Montalbetti and
Falque, 2005).
The most-widely used coupling reagents are carbodiimides
(Fig. 1) on one hand, and phosphonium and aminium salts
on the other (Sheehan and Hess, 1955; Castro et al., 1975; Cos-
te et al., 1990; Li and Xu, 2001; Carpino et al., 2002). Phospho-
nium and aminium salts, which has a general structure as
shown in Fig. 1 (Williams and Ibrahim, 1981).
2.2.1. Carbodiimides (Rich and Singh, 1979)
Reaction of a protected carboxylic acid with a carbodiimide is
believed to involve a labile O-acylisourea (8), which reacts with
the amino component to give the corresponding amide
(Scheme 3). If 2 equiv. of carboxylic acid are used, the interme-
diate O-acylisourea reacts with the second equivalent of car-
boxylic acid to give the corresponding symmetric anhydride
(9). If the activated process is carried out in the presence of
a hydroxylamine derivative {HOXt; N-hydroxysuccinimide
(HOSu, 10) (Knorr et al., 1989), 1-oxo-2-hydrox-
ydihydrobenzotriazine (HODhbt, 11) (Ko¨nig and Geiger,
1970a), 1-hydroxybenzotriazole (HOBt, 12) (Ko¨nig and
Geiger, 1970b), 7-aza-1-hydroxybenzotriazole (HOAt, 13)
(Anderson, 1970; Carpino, 1993; Gibson et al., 1994), or 1-
hydroxy-1,2,3-triazole derivatives (14, 15, 16, and 17), N-
hydroxytetrazole (HOt, 18) (Majestich et al., 1998; Spetzler
et al., 1998), or ethyl 1-hydroxy-1H-1,2,3-triazole-4-carboxyl-
ate (HOCt, 19) (Jiang et al., 1998; Robertson et al., 1999)},
and the most recent additive ethyl-2-cyano-2-(hydroxyimi-
no)acetate (Oxyma, 20) (Subiro´s-Funosas et al., 2009), an ac-
tive ester 21 is obtained, as shown in Scheme 3. Anyone of
the three active species, O-acylisourea (8), symmetric anhy-
dride (9), or active ester 21 is an excellent acylating reagent.
The notion of replacement of the benzene ring in typical ac-
tive esters by the aromatic heterocyclic ring has inspired the
designing of new reagents useful for the formation of the pep-
tide bond. Esters of 2-hydroxypyridine (Effenberger and
Brodt, 1985), pyrimidine (Kim and Kim, 1985), pyrazoline
(Hudson, 1990), 8-hydroxyquinoline (Jakubke et al., 1967),
hydroxybenzotriazole, 1,2,3-triazolopyrydin-3-ol (Carpino
and El-Faham, 1994), and many others (Janoschek, 1993;
Griehl et al., 1998; Bailen et al., 1999; Zacharie et al., 1999)
have been accepted standards, are still in use, for the prepara-
tion of peptides. Many other heterocyclic compounds are
currently being developed (Kamin´ski, 2000).
The effects of electron-withdrawing may decrease electron
density at the carbon atom of the ester group directly attached
ON C N N C NH
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Scheme 3 Mechanism of peptide bond formation through carbodiimide.
Recent development in peptide coupling reagents 101to the ring, thereby increasing its reactivity towards nucleo-
philes and thus improving active esters was based on increas-
ing the number of electronegative heteroatoms in the ring
(Kamin´ski, 2000). Some oximes reported as alcoholic compo-
nents of active esters seem to be good nucleophiles, but the
reactivity of these esters is somewhat lower than those of other
types of active esters. It was expected, therefore, that strongly
acidic and nucleophilic oximes, which possess electron-with-
drawing groups in the molecule, might be suitable as additives
(Bittner et al., 1965; Handford et al., 1965; Losse et al., 1965;
Fujino and Nishimura, 1969).
The main advantage of using N-hydroxy compounds as
additives is to reduce loss of conﬁguration at the carboxylic
acid residue (Carpino et al, 1995).
The HODhbt (11) reaction is accompanied by formation of
a by-product namely 3-(2-azidobenzoyloxy)-4-oxo-3,4-dihy-
dro-1,2,3-benzotriazine (24), which itself can react with the
amino group to terminate chain growth (Scheme 4) (Ko¨nig
and Geiger, 1970a; Albericio et al., 1998). 7-Aza-1-hydroxy-
benzotriazole (HOAt, 13) has been described as being superior
to HOBt (12) and its derivatives (Carpino et al., 1994a,b, 2000;
Wijkmans et al., 1995; Kehler et al., 1996; Quibell et al., 1996;
Carpino and El-Faham, 1999; El-Faham et al., 2006) 6-CF3-
HOBt (22) or 6-NO2-HOBt (23) as an additive for both solu-
tion and solid-phase synthesis.HOAt (13) enhances coupling rates and reduces the risk of
racemization (Carpino et al., 1994a,b, 2000; Quibell et al.,
1996; Carpino and El-Faham, 1999), possibly because it incor-
porates into the HOBt (12) structure a nitrogen atom strategi-
cally placed at position-7 of the aromatic system.
Incorporation of a nitrogen atom in the benzene ring has two
consequences. First, the electron withdrawing inﬂuence of a
nitrogen atom (regardless of its position) effects stabilization
of the leaving group leading to greater reactivity. Second,
placement speciﬁcally at the 7-position makes feasible a classic
neighboring group effect (Fig. 2) (Dourtoglou et al., 1984;
Knorr et al., 1989; Kiso et al., 1992; Carpino, 1993; Abdelmoty
et al., 1994; Carpino et al., 1994b, 1995, 2001; Boﬁll and
Albericio, 1996; Albericio and Carpino, 1997; Albericio and
Kates, 2000; Albericio et al., 2001; Han and Kim, 2004;
Benoiton, 2006), which can both speed up the reactivity and re-
duce the loss of conﬁguration. The corresponding 4-HOAt (27),
5-HOAt (28), and 6-HOAt (29) lacking the ability to take part in
such a neighboring group effect have no inﬂuence on extent of
stereomutation during segment coupling reaction relative to
HOBt (12).
Subiro´s-Funosas et al. (2009) recently reported safe and
highly efﬁcient additive Oxyma (20) to be used mainly in the
carbodiimide approach for forming the peptide bond. Oxyma
(20) displays a remarkable capacity to suppress racemization
N N
N
N
R2N
H O
R
Figure 2 Neighboring group effect for HOAt (13).
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102 T.I. Al-Warhi et al.and an impressive coupling efﬁciency in both automated and
manual synthesis.
For carrying out SPPS by Boc/benzyl (Bzl) strategy, among
carbodiimides, the N,N0-dicyclohexyl carbodiimide derivative
(DCC, 25) is the most widely used. In the DCC method using
additives, Anderson (1970) has concluded that a major factor
for racemization suppression was not neutralization of basicity
of DCC (25) by an additive, but its nucleophilic reactivity, the
by-products N,N0-dicyclohexyl urea (DCU, 26) can be elimi-nated from the reaction vessel due to its solubility during re-
moval of the Boc (1) group with triﬂuoroacetic acid (TFA).
The high solubility in N,N-dimethylformamide (DMF) of the
urea derived from N,N0-diisopropylcarbodiimide (DIC, 30)
makes it the carbodiimide of choice when the Fmoc/t-Bu
strategy is used. In fact, use of DCC (25) is not possible in this
case, since (DCU, 26) would plug the frit of either the reaction
vessel or the column in the case of batch or continuous-ﬂow
synthesis, respectively. Finally, 1-ethyl-3-(30-dimethyl-amino-
propyl)carbodiimide hydrochloride (EDC.HCl, 31), the urea
by-product, which is soluble in aqueous solvent mixtures, is
mainly used for synthesis carried out in solution. The newer
carbodiimide 1,3-bis(2,2-dimethyl-1,3-dioxolan-4-ylmethyl)car-
bodiimide (BDDC, 32) is also used for solution-phase peptide
couplings with a maximum of 1.3% of epimerization (Gibson
et al., 1994).Carbodiimide-mediated coupling reagents are usually car-
ried out with the preactivation of protected amino acid, at
either 25 C or 4 C. If desired, after ﬁltration of DCU (26)
and evaporation of dichloromethane (DCM), DMF may be
used as the coupling medium (Merriﬁeld et al., 1982). In
DMF where the activation process is slow, hindered base such
as 2,4,6-trimethylpyridine (collidine; TMP) could be used to
enhance the step involving preactivation of the carboxylic acid
residue in contrast to the normal situation, in which bases such
Recent development in peptide coupling reagents 103as diisopropylethylamine (DIEA), N-methylmorpholine
(NMM) or non hindered pyridine bases inhibit this step (Car-
pino and El-Faham, 1999). Comparison of coupling yields ob-
tained in the presence of pyridine, triethylamine (TEA),
NMM, and N,N-dimethylaniline (DMA) in solvents such as,
tetrahydrofuran (THF), acetonitrile, DMF, N,N-dimethylacet-
amide and N-methylpyrrolidone reveal again that the best
yield is obtained when the activation proceeds under standard
conditions (Kamin´ski, 1985).
For large-scale synthesis (ca. 10 mmol of peptide), it is man-
datory to preactivate at 4 C, because the exothermic nature of
the reaction increases the risk of racemization, even when ure-
thane-type protecting groups are used.
2.2.2. Phosphonium and aminium salts
2.2.2.1. Phosphonium salts. Gawne et al. (1969) were the ﬁrst to
describe the use of phosphonium salts as coupling reagents,
these species have only been widely adopted after the extensive
studies of Castro and Dormoy (1973), Castro et al. (1975,1977)
and Coste et al. (1990), who described the applicability of
(benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexa-
ﬂuorophosphate (BOP, 33) and (benzotriazol-1-yloxy)tris(pyrr-
olidino)phosphonium hexaﬂuorophosphate (PyBOP, 34).N
N
N
(NMe2)3
33 (BOP)
N
N
N
N
34 (PyBOP)
3
O (NMe2)3
36 (HMPA)
N
N
N
35 (BOMP)
N
N
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O P
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O P
PF6The BOP reagent (33) has been used in many syntheses since
it is easy to use and promotes rapid coupling. However, it
produces hexamethylphosphorotriamide (HMPA, 36) as a side
by-product, which has been classiﬁed as a potential human car-
cinogenic (Dykstra, 1995). PyBOP (34) is a good substitute that
presents all of the advantages of BOP reagent (33) and yields
less noxious by-products. Later, 2-(benzotriazol-1-yloxy)-1,
3-dimethyl-2-pyrrolidin-1-yl-1,3-diazaphospholidinium hexa-
ﬂuorophosphate (BOMP, 35) was used as an effective condens-
ing reagent for rapid internucleotidic bond formation (Wada
et al., 1997). It may also represent a new, useful reagent for pep-
tide coupling. The main mechanistic pathway involved in cou-+ R C O
O
N
N
N
O P (NMe  )   2 3
33 (BOP)
PF6
Scheme 5 Mechanism of BOPpling reactions mediated via BOP (33) and related reagents, is
probably that as shown in Scheme 5.
Formation of OBt ester (37) is achieved in the presence of
1 equiv. of a tertiary base, such as diisopropylethylamine
(DIEA), N-methylmorpholine (NMM) (Kim and Patel, 1994;
Campagne et al., 1995; Coste and Campagne, 1995), or colli-
dine (TMP) (Carpino and El-Faham, 1994; Carpino et al.,
1996a). The presence of an extra equivalent of HOBt (12)
can accelerate the coupling process as well as reduce the loss
of conﬁguration (Hudson, 1988). Some controversy has arisen
regarding the possible intermediacy of an acyloxyphosphoni-
um salt and its life time. Kim and Patel (1994) reported that
such intermediates could exist at 20 C in the absence of ex-
cess of HOBt (12). On the other hand, Coste and co-workers
(Campagne et al., 1995; Coste and Campagne, 1995) suggested
that this species is very unstable and even at low temperature
undergoes conversion to the active ester.
Phosphonium salts derived from HOAt (13), such as (7-aza-
benzotriazol-1-yloxy)tris(di-methylamino)phosphonium hexa-
ﬂuorophosphate (AOP, 38) and (7-azabenzotriazol-1-yloxy)tris
(pyrrolidino)phosphoniumhexaﬂuorophosphate (PyAOP,39) have
also been prepared and are generally more efﬁcient than BOP (33)
andPyBOP (34) as coupling reagents (Carpino et al., 1994b; Ehrlichet al., 1996;Kates et al., 1996;Albericio et al., 1997;Han et al., 1997;
Jou et al., 1997). The pyrrolidino derivative PyAOP (39) is slightly
more reactive than the dimethylamino derivatives AOP (38), and
in the activation step does not liberate HMPA (36).
N
N
N
(NMe2)3
38 (AOP)
N
N
N
N
39 (PyAOP)
3
NN
O P
PF6
O P
PF6R C O
O
P (NMe2)3
R C OBt
O
+ O P (NMe2)3
36 (HMPA)37
OBt
-mediated coupling reagent.
104 T.I. Al-Warhi et al.Intramolecular peptide forming reaction is the key step in
the synthesis of constrained head-to-tail cyclopeptides due to
the high tendency of the corresponding linear peptides to oli-
gomerize. Classical approaches to the synthesis of a cyclic pep-
tide generally involve preparation of the partially protected
linear precursor (by solution or solid-phase approaches), fol-
lowed by cyclization in solution under high dilution condi-
tions. However, solution-phase methodologies, even in high
dilution conditions, suffer from several drawbacks, such as
cyclodimerization and cyclooligomerization side reactions. If
the peptide remains anchored on a solid support, the cycliza-
tion takes advantage of the pseudodilution phenomenon,
which favors intramolecular resin-bound reactions and thus
minimizing interchain interactions (Rovero, 2000). It is already
well-known that the cyclization with aminium (uronium) salts
should be generally performed without excess of coupling re-
agent (1 equiv. of coupling reagent in the presence of 2 equiv.
of tertiary base), to avoid the formation of guanidinium side
products (Fernso et al., 2000). The same conditions (stoichi-
ometric amounts of reagent) were applied, to compare the efﬁ-
cacy of all reagents under the same conditions. In all
experiments, the cyclization yield (%) was determined as a ra-
tio between the concentration of the cyclopeptide and the cor-
responding linear peptide isolated after the cleavage from the
resin (Kamin´ski et al., 2005).
It has been found that PyAOP (39) is very effective in the
solution phase cyclization of all L-pentapeptide, a very difﬁcult
case due to the restricted conformational ﬂexibility of the lin-
ear precursor (Jou et al., 1997). For example, for the cycliza-
tion of H-Arg(NO2)-Lys(Z)-Asp(OBn)-Val-Tyr-OH, PyAOP
(39) gave 56% cyclomonomer with only 10.9% of the D-Tyr-
isomer after 1 h, whereas PyBOP (34) led to 52% cyclomono-
mer with 13% D-isomer and BOP (33) to only 38% of the de-
sired product with 20.2% C-terminal epimerization. In the
course of the cyclization of H-Arg(H+)-Lys(Ac)-Ala-Val-
Tyr-OH, only 8.7% C-terminal epimerization was detected
for PyAOP (39) whereas for PyBOP (34) and BOP (33), epi-
merization level reached 16.8% and 20.7%, respectively. By
use of the same solution phase cyclization technique, the po-
tent immunosuppressive and anticancer didemnins (40) were
synthesized in excellent yields (70%) using PyAOP (39) in
the presence of HOAt (13) (Albericio et al., 1997).
NH
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R' HO
OMe
RMeN
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O
PyAOP/HOAt, 70%
HATU/HOAt, 76%
PyBrOP, 37%
didemnin A:       R' = Me, R = H
didemnin B:       R' = Me, R = Lac-Pro
nor-didemnin B: R' = H,   R = Lac-Pro
40
Further research has revealed that PyAOP/HOAt is also an
effective reagent for cyclization of the highly hindered N-meth-
ylamino acids (Kates et al., 1996; Han et al., 1997).
In the course of the chemical synthesis of oligodeoxyribo-
nucleotides, Wada et al. (1997) found that PyAOP (39) was
a highly reactive internucleotidic bond coupling. For conden-sation of an H-phosphonate monomer with 2 equiv. of 30-O-
(phenoxyacetyl)thymidine (41) in CD3CN-pyridine, the half-
life time for the reaction with PyAOP (39) is only 4 min, in
comparison with the corresponding ﬁgures for PyBOP (34)
(12 min), BOP (33) (125 min) and PyDOP (42) (18 h).OH
O
O
N
O
HN
O O
O
41
Several other HOBt (12) derivatives (Wijkmans et al., 1995;
Kehler et al., 1996) bearing an electron-withdrawing group at
the 6-position of the HOBt ring, such as 6-nitro-1-hydroxyben-
zotriazole (43), 6-triﬂuoromethyl-1-hydroxybenzotriazole (44),
and 4-nitro-6-triﬂuoromethyl-1-hydroxybenzotriazole (45)
were prepared and used in peptide coupling reactions.
While [(6-nitrobenzotriazol-1-yl)oxy]tris(pyrrolidino)phos-
phonium hexaﬂuorophosphate (PyNOP, 43) (Høeg-Jensen
et al., 1994, 1996; Wijkmans et al., 1995; Kehler et al., 1996),
[[6-(triﬂuoromethyl)benzotriazol-1-yl]oxy]tris(pyrroli-dino)phos-
phonium hexaﬂuorophosphate (PyFOP, 44) (Høeg-Jensen et al.,
1994, 1996; Kim and Patel, 1994; Campagne et al., 1995; Coste
and Campagne, 1995), [[4-nitro-6-(triﬂuoromethyl)benzotriazol-
1-yl]oxy]tris(pyrrolidino)phosphonium hexaﬂuorophosphate
(PyNFOP, 45), and [(6-nitrobenzo-triazol-1-yl)oxy]tris(di-
methyl-amino)phosphonium hexaﬂuorophosphate (NOP, 46)
(Høeg-Jensen et al., 1994), were only used inpeptide thioacylation
and rapid internucleotidic bond formation, they should be appli-
cable to peptide synthesis.
Meanwhile, as alternative to the BOP reagent (33), 1-b-
naphthalenesulfonyloxy benzotriazole (NSBt, 47) (Nakajima
et al., 1988; Kundu et al., 1989, 1994) and 1-b-naphtha-
lenesulfonyloxy-6-nitrobenzotriazole (N-NSBt, 48) (Devadas
et al., 1993; Kundu and Agarwal, 1996) have also been demon-
strated to be efﬁcient peptide coupling reagents in solid and
solution phase synthesis.
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Recent development in peptide coupling reagents2.2.2.2. Uronium/aminium salts. Aminium salt bearing a posi-
tive carbon atom in place of the phosphonium residue have also
been reported (Dourtoglou et al., 1984; Knorr et al., 1989; Kiso
et al., 1992; Carpino, 1993; Carpino and El-Faham, 1994, 1999;
Carpino et al., 1994a,b, 1996a, 2000; Quibell et al., 1996; Carpi-
no and El-Faham, 1999) and aminium salt initially assigned an
uronium-type structure, HBTU (49) and HATU (50) presum-
ably by analogy with the corresponding phosphonium salts. La-
ter (Abdelmoty et al., 1994; Boﬁll and Albericio, 1996; Carpino
et al., 2001), it has been determined by X-ray analysis that N-
[(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylme-
thanaminium hexaﬂuorophosphate N-oxide (N-HBTU, 51), N-
[(dimethylamino)-1H-1,2,3-triazolo[4,5-b]pyridin-1-ylmethyl-
ene]-N-methylmethanaminium hexaﬂuorophosphate N-oxide
(N-HATU, 52), and 1-(1-pyrrolidinyl-1H-1,2,3-triazolo[4,5-
b]pyridin-1-yl-methylene)pyrrolidinmium hexaﬂuorophos-
phate N-oxide (HAPyU, 53) (Carpino and El-Faham, 1994;
Carpino et al., 1996a; Fernso et al., 2000; Li and Xu, 2000) crys-
tallize as aminium salts (guanidinium N-oxides) rather than the
corresponding uronium salts (49 and 50). NMR studies in the
case of HAPyU (53) show that the same structure is found in
solution (Carpino et al., 2001).X N
N
N
O
NMe2Me2N
49 (HBTU); X = CH
50 (HATU); X = N
PF6
N
N
N
X
O
C
Me2N NMe2
51 (N-HBTU); X = CH
52 (N-HATU); X = N
N
N
N
N
O
C NN
53 (HAPyU)
PF6 PF6TBTU (54) and TATU (55), the tetraﬂuoroborates salts re-
lated to 49 and 50, have also been prepared and used in SPPS.
A series of novel aminium type coupling reagents such as
{(BOMI, 56), (DOMP, 57), (BDMP, 58), (AOMP, 59), (FOMP,
60) and (SOMP, 61)}, were designed, synthesized and used in
peptide synthesis (Devadas et al., 1993; Kundu and Agarwal,
1996; Rovero, 2000). It was shown that most of these reagents
were more efﬁcient in the form of HOAt-based coupling re-
agents than their HOBt analogous in terms of reactivity and
racemization control in both solution and solid phase peptide
synthesis (Fernso et al., 2000; Li and Xu, 2000).65 66 (OPfp) 67 (OTcp) 68 (ONp)
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Figure 3 Oxazolone (65) and esters (66–68).X N
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SbCl6 SbCl6 SbCl6HOAt-based uronium reagents are also very favorable for
the coupling of hindered amino acids shown by excellent syn-
thesis of peptide containing consecutive N-methylamino acids
or 2-aminoisobutyric acid (Aib) or diethyl glycine (Deg) units
(Fre´rot et al., 1992; Schnoelzer et al., 1992; Sapia et al., 1995;
Humphrey and Chamberlin, 1997; Marsh et al., 1997).
Novel series of coupling reagents contain alternative leav-
ing groups, e.g. pentaﬂuorophenyl (HPyOPfp, 62), P-nitro-
phenyl (HPyONp, 63) and 2,4,5-trichlorophenyl (HPyOTcp,
64) were synthesized and used in coupling reactions (Haber-
mann and Kunz, 1998a; Klose et al., 1999; El-Faham, 2000).
FF
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Comparison of the effectiveness of these reagents by cycli-
zation of the sequence Ala-Ala-MeAla-Ala-Ala, (3 + 3) seg-
ment condensation, Z-Gly-Gly-Val-OH + Ala-Gly-Gly-
PAL-PS (Klose et al., 1999) and (2 + 1) segment condensa-
tion, Z-Phe-Val-OH+ Pro-PAL-PS (Klose et al., 1999; El-Fa-
ham, 2000), following the standard protocol (Ehrlich et al.,
1993; Carpino et al., 1995), shows a clear superiority for the
HOAt-derived coupling reagents HAPyU (53) and HATU
(50) (in the presence or absence of HOAt (13)) relative to those
derived phenol-based coupling reagents both in terms of reac-
tion rates and epimerization.
The effectiveness of various coupling reagents (e.g. 39, 50,
53, 62) appears to be strongly inﬂuenced by the nature of the
‘active ester’ and less by that of the uronium/guanidinium/
phosphonium component. Moreover, the results indicate dif-
ferent mechanism for HOAt (13) and phenol-derived coupling
reagents and are supported by IR experiment (El-Faham,
2000), it has been concluded that reactions of the HOAt-de-
rived coupling reagents involve a highly reactive intermediate,
probably the OAt ester, whereas phenol-derived coupling
reagents are promoted reactions that involve the intermediacy
of oxazolone (65) and relatively less reactive OPfp (66), OTcp
(67), ONp (68) esters (Fig. 3).
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106 T.I. Al-Warhi et al.From HPLC analysis remarkably high epimerization levels
are observed for the phenol-based coupling reagents due to the
formation of oxazolone (El-Faham, 2000). It has been shown
previously that for other coupling reagents known to generate
oxazolones, the addition of HOAt (13) effects a shift to the
safer, more reactive OAt ester (Akaji et al., 1994, 1996; Carpi-
no et al., 1996a; El-Faham, 1998a). The addition of HOAt (13)
strikingly improved the results for the HOPfp-derived coupling
reagents compared to the analogous reactions carried out in
absence of HOAt (13) (Klose et al., 1999; El-Faham, 2000).
Recently, Carpino et al. (2004a) reported the new coupling
reagents (HDATU, 69) and (HDAPyU, 70). These were pre-
pared by a method analogous to that used for the preparation
of (HDTU, 71) (Carpino et al., 1995).
69 (HDATU); X = N
71 (HDTU); X = CH 70 (HDAPyU)
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OEl-Faham and Albericio described a new family of immoni-
um-type coupling reagents based on the differences in the carbo-
cation skeletons of coupling reagents which correlated with
differences in stability and reactivity (El-Faham et al., 2006,
2009; El-Faham andAlbericio, 2007, 2008). The dihydroimidaz-
ole derivatives are highly hygroscopic, while the salts derived
fromdimethylmorpholino are themost stable, and the pyrrolidi-
no derivatives are of intermediate stability. Regarding both cou-
pling yield and retention of conﬁguration, derivatives of OxymaN
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Scheme 6 Synthesis of non-symmetr(COMU, 72) have been conﬁrmed to show superior performance
to those of HOBt (12) in all cases and the same performance as
HOAt (13) or sometimes better. The recent uronium-type re-
agents can be readily prepared by treatingN,N-dialkylcarbamoyl
chloride 73with secondary amines, such as diethylamine, pyrrol-
idine, piperidine or morpholine to give the corresponding urea
derivatives 74 (Scheme 6). The urea derivatives then react with
oxalyl chloride to yield the corresponding chlorosalts 75
(Scheme 6), which is stabilized by the formation of a PF6 salt.
Subsequent reaction with HOXt (X= A or B) in the presence
of a tertiary amine such as Et3N affords the desired compound
76 as crystalline and shelf-stable solids (Scheme 6).
Mechanistically, aminium/uronium salts are thought to
function in a similar manner to the phosphonium analogues
(Scheme 7). Formation of carboxyl uronium salts, which gen-
erate an active ester is achieved in the presence of 1 equiv. of
tertiary base such as, DIEA, NMM, or TMP (Carpino and
El-Faham, 1994; Carpino et al., 1996a).
2.2.3. Fluoroformamidinium coupling reagents
Among the most reactive of the common coupling reagents are
the preformed amino acid ﬂuorides. A more convenient meth-
od of making use of these efﬁcient reagents is to generate the
acid ﬂuorides in situ via the aminium reagents 1,1,3,3-tetram-
ethylﬂuoroformamidinium hexaﬂuorophosphate (TFFH, 77)
(Carpino and El-Faham, 1995; Carpino et al., 1996b), bis(tet-
ramethylene)ﬂuoroformamidinium hexaﬂuorophosphate
(BTFFH, 78) (El-Faham, 1998b) and 1,3-dimethyl-2-ﬂuoro-
4,5-dihydro-1H-imidazolium hexaﬂuorophosphate (DFIH,
79) (El-Faham, 1998a) with these reagents even His and Arg,
which are the only two proteinogenic amino acids that can
not be converted to shelf-stable Fmoc-protected amino acid-(COCl)2
2-KPF6
N
N
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ic uronium-type coupling reagents.
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Scheme 7 Proposed mechanism for activation by uronium salt.
Recent development in peptide coupling reagentsﬂuorides, can be routinely coupled in this form. In some cases
for these two amino acids as well as for Asn, better results are
obtained if 1 equiv. of HOAt (13) is present during the cou-
pling process (Akaji et al., 1994; Carpino and El-Faham,
1995; Carpino et al., 1996b; Quibell et al., 1996; El-Faham
and Albericio, 2008).
N C F
N
N C F
N
    77 (TFFH)                         78 (BTFFH)
N
N
F
79 (DFIH)
PF6PF6 PF6R-C-OH
O
+ F
Me2N
Me2N PF6 Base
Scheme 8 Synthesis of N-protected amInfrared examination shows that in the presence of DIEA,
Fmoc-Amino acids are converted to the acid ﬂuorides by mean
of (TFFH, 77) or its analogous (Carpino and El-Faham, 1995;
Carpino et al., 1996b; El-Faham, 1998a,b).
IR absorption (CH2Cl2 solution) characteristic of the car-
bonyl ﬂuoride moiety (1842 cm1) appears after 3 min, with
complete conversion to the acid ﬂuoride occuring after 8–
15 min. If desired, the acid ﬂuorides can be isolated and puri-
ﬁed (Carpino and El-Faham, 1995; Carpino et al., 1996b; El-
Faham, 1998a,b) (Scheme 8).
The related chloroformamidinium salt CIP (80) in presence
of HOAt (13) as additive (Akaji et al., 1994, 1997; Kuriyama
et al., 1997) mediates the solution phase 2-aminoisobutyric
acid (Aib) coupling in excellent yield (82-90% for Z-Aib-
Aib-OMe) (Akaji et al., 1994). Two peptaibols, Ac-Aib-Pro-
Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-
Aib-Glu-Gln-Pheol (alamethicin F-30) and Ac-Aib-Asn-Leu-
Aib-Pro-Ala-Val-Aib-Pro-Aib-Leu-Aib-Pro-Leuol (trichovirin
I4-A) were successfully synthesized using CIP/HOAt coupling
techniques (Akaji et al., 1997). For Fomc-Aib-OH (81) activa-
tion, the CIP-mediated reaction proceeds ﬁrst through the oxa-
zolone (82) and then through HOAt active ester (83)
(Scheme 9) (Akaji et al., 1994, 1996; El-Faham, 1998a).
The use of these various onium salts requires careful atten-
tion to the tertiary base used and the preactivation time.
Although, in the case of some authentic synthesizers, the pre-
activation time comes dictated by the instrument; in others and
for manual synthesis it can be modulated. For onium salts
incorporating HOAt (13), the activation of ordinary amino
acids gives the corresponding OAt esters almost instantly.
Thus, in such cases, the preactivation time should be kept to
the minimum, since on standing alone the activated species
can give rise to several side-reactions including racemization,
formation of d-lactam (Arg), cyno derivatives (Asn or Gln),
or a-aminocrotonic acid (Thr). The same consideration applies
to coupling reagents, which incorporate HOBt (12).
Regarding the use of a base during the coupling process, for
those coupling reactions, which involve amino acids which are
not likely to lose their conﬁguration (all except Cys and His),
the reactions are carried out in the presence of 1.5–2 equiv. of a
tertiary amine, such as DIEA or NMM. For the coupling of
protected peptides, where resistance to conversion to oxazo-
lone does not apply, and for the coupling of Cys and His,
the use of only 1 equiv. of a weaker or more hindered base is
107O
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Scheme 9 CIP-mediated reaction.
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108 T.I. Al-Warhi et al.to be more recommended. For such systems, 2,4,6-trimethyl-
pyridine (collidine, TMP) and the more basic 2,6-di-tert-bu-
tyl-4-(dimethylamino)pyridine (DB(DMAP)) are very
promising (Carpino and El-Faham, 1994; Carpino et al.,
1996a).
2.2.4. Organophosphorus reagents
Since Yamada introduced the mixed carboxylic-phosphoric
anhydride method using DPPA (84) from diphenylphospho-
rochloridate and sodium azide to peptide chemistry in 1972
(Shioiri et al., 1972; Shioiri and Yamada, 1974), various orga-
nophosphorus compounds have been developed as peptide-
coupling reagents (Fig. 4). This method usually gives higher
regioselectivity towards nucleophilic attack by the amine com-
ponent than a mixed carbonic anhydride method (Takeuchi
and Yamada, 1974; Jackson et al., 1976).
Modiﬁcation of DPPA (84) has led to the development of
thiophosphinic-type coupling reagents such as MPTA (88)
and MPTO (89) (Fig. 4) (Ueki et al., 1979; Ueki and Inazu,
1982; Katoh and Ueki, 1993).
These reagents are crystalline and stable for long-term stor-
age. Since MPTA (88) generated a carbamoyl azide or urea
derivative as the by-product, Ueki introduced MPTO (89), in
which the azide group of MPTA (88) is replaced by a 2-oxazo-
lone group. On the basis of the earlier development of organo-
phosphorus reagents, a great amount of effort has been
focused on developing various coupling reagents of a similar
kind. For example, NDPP (91) (Kiso et al., 1980), Cpt-Cl
(92) (Ramage et al., 1984; Poulos et al., 1992), BMP-Cl (93)
(Miyake et al., 1985; Panse and Kamat, 1989), DEBP (94)
(Kim et al., 1985), BDP (95) (Watanabe and Mukaiyama,
1981), bis(o-nitrophenyl)phenyl phosphonate (Mukaiyama
et al., 1981), (5-nitro-pyridyl)diphenyl phosphinate (Kunieda
et al., 1981), diphenyl 2-oxo-3-oxazolinyl phosphonate (Ueda
and Oikawa, 1985), and 1,2-benzisoxazol-3-yl diphenyl phos-P
O
N3O
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P
O
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Figure 4 Structures of orgphate (Fan et al., 1996) have been prepared by several research
groups (Fig. 5).
More recently, Ye developed DEPBO (96), DOPBO (97),
DOPBT (98), and DEPBT (99) (Fig. 6) (Li et al., 1999; Xie
et al., 2000; Tang et al., 2002). DEPBT (99) derived from
DEPC (87) and HODhbt (11) has been evaluated against otherP
S
N3
P
S
N
O
OCH3
CH3 O
O
P
O
Cl
Ph
Ph
PTA) 89 (MPTO) 90 (DPPCl)
anophsphorus reagents.
NO2
NH2
NaH, BnBr
700C, 3hr N
N
Ph
OBn
N
N
Ph
OH
H2, Pd/C
MeOH, 15min
N
N
Ph
O
P
R
O
R
R2POCl Et3N, DCM, 0 0C
101a; R = OEt
101b; R = OPh
101c; R = Ph
102
Scheme 10 Synthesis of phosphorus reagents of 1-hydroxy 2-phenylbenimidazole (102).
Recent development in peptide coupling reagents 109peptide-coupling reagents and gave good results in segment
coupling reactions. Although the racemization-suppressing
capacity of HODhbt (11) is greater than that of HOBt (12),
its utility was limited due to side reactions.
Later Carpino et al. (2004b) introduced new organophos-
phorus reagents (100, Fig. 6). In this case the neighboring
group effects believed to be relevant to the properties of HOAt
(13) are superimposed on the effects that enhance the efﬁciency
of the phosphorus moiety. On the basis of the results de-
scribed, these effects are related to the greater speed with which
protected amino acids are converted to their active esters by
the phosphorus derivatives. Long-term storage, unfortunately,
requires great care because of the hydrolytic sensitivity of these
materials. Given that these new phosphate esters are clearly
superior to the older uronium/guanidinium reagents for seg-
ment coupling and, under certain conditions, for solid-phase
peptide assembly, it was considered essential to search for re-
agents with greater shelf stability.
Recently (Kokare et al., 2007), phosphoric acid diethyl ester
2-phenylbenzimidazol-1-yl ester (101a), diphenylphosphinic
acid 2-phenylbenzimidazol-1-yl ester (101b) (Scheme 10) and
phosphoric acid diphenyl ester 2-phenylbenzimidazol-1-yl ester
(101c) have been reported as highly efﬁcient coupling reagents.
Their efﬁciency was evaluated through the synthesis of a range
of amides and peptides, and the extent of racemization was
found to be negligible. 1-Hydroxy-2-phenylbenzimidazole
(102) was synthesized by coupling ortho-nitroaniline with ben-
zyl bromide using sodium hydride as base, followed by benzyl
deprotection (Scheme 10) (El-Faham and Albericio, 2009). The
coupling reagents phosphoric acid diethyl ester 2-phen-
ylbenzimidazol-1-yl ester (101a), diphenylphosphinic acid
2-phenylbenzimidazol-1-yl ester (101b) and phosphoric acid di-
phenyl ester 2-phenylbenzoimidazol-1-yl ester (101c) were syn-
thesized by reaction of 102 with diethyl chlorophosphate,
diphenylphosphorochloridate or diphenylphosphinic chloride,
respectively, using TEA base in DCM.
2.2.5. Triazine coupling reagents
1,3,5-Triazines have also been used as coupling reagent. Thus
the highly reactive 2,4,6-trichloro-1,3,5-triazine (cyanuric chlo-
ride, 103) produced by trimerization of chlorocyane is manu-
factured on the scale of several millions tons per year and is
among the lowest price reagents. Derivatives of cyanuric chlo-
ride (CC, 103) have found numerous applications as herbi-
cides, in the dyestuff industry, polymer manufacturing,explosives, and many others. Their reactivity and properties
have been studied most intensively. Considering any potential
application of triazines as donors of an acyl group, the most
symmetric 1,3,5-triazines (104) can be recognized as the most
promising target (Kamin´ski, 1985). It is only in the case of
symmetric 1,3,5-triazine (104) that each acyl group (derivatives
105–107) can be transferred to the nucleophile via the intramo-
lecular nucleophilic assistance of nitrogen atoms.
103 (CC)
N
N
N
ClCl
Cl
104
N
N
N
N
N N
YO
X
O R
105
N
N N
OO
X
O R
106
O
R
N
N N
OO
O
RO
O
R
O
R
107
1,3,5-Triazines (104) bearing one acyl group can form sev-
eral isomeric structures, resulting from partial or total Oﬁ N
migration of substituents. Most of these have been synthesized
and isolated in the pure form or at least identiﬁed as interme-
diates in reactions.
The anticipated higher reactivity of imine functionality,
which is present in structures (108–113), and the increased risk
of migration of substituents and double bonds in the non aro-
matic but partially unsaturated triazine ring, opens the possi-
bility for many synthetic applications, but deﬁnitely has the
important disadvantage considering the requirements of pep-
tide preparation. However, acyl derivative (114), which bears
a completely saturated ring, has to be recognized as a more
promising acylating reagent than its other partially unsatu-
rated counterparts (108–113).
Bearing in mind the synthetic potential of acyl derivatives
of triazine and the convenient preparation of the whole family
of 1,3,5-triazines (104) from the inexpensive cyanuric chloride
(CC, 103), it has been found valuable to develop these closely
related compounds into the new group of triazine-based con-
densing reagents (TBCRs).
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Scheme 11 Synthesis of 2,4,6-tris(penta ﬂuorophenyloxy)-1,3,5-
triazine (TPfT, 117).Cyanuric chloride (CC, 103), 2,4-dichloro-6-methoxy-1,3,5-tri-
azine (DCMT, 115), and 2-chloro-4,6-dimethoxy-1,3,5-triazine
(CDMT, 116) are the TBCRs commercially available from
chemical reagent suppliers. In the laboratory, these TBCRs
as well as numerous analogues can be readily prepared from
(CC, 103) by substitution of one or two chlorine atoms with
the appropriate nucleophile. Usually substitution proceeds
stepwise (Dudley et al., 1951; Kamin´ski, 2000).
(CC, 103), the parent compound of all TBCRs, has been
successfully used as a condensing reagent in the preparation
of amides (Baccolini et al., 1969; Rayle and Fellmath, 1999),
dipeptides (Venkataraman and Wagle, 1979), macrocyclic
lactones (Venkataraman and Wagle, 1980), formation of the
b-lactam ring, etc. Cyanuric chloride (CC, 103) activation of
carboxylic acids followed by condensation with esters of alky-
loiminocarboxylic acids (Schiff bases) afforded the b-lactam
ring (Manhas et al., 1981). The excessive reactivity of (CC,
103) creates serious problems when this reagent is used for
the synthesis of multifunctional compounds. These impair
the chance of its comprehensive application in the peptide syn-
thesis, but certainly do not exclude its application to a limited
extent (Kamin´ski, 2000).N
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Scheme 12 Synthesis of 2,4-diacyloxy-6-methoxy-1,3,5-triazines
(120).The application of chiral coupling reagents for enantioselective
incorporation of uncoded amino acids, often available in both
conﬁgurations but in the racemic form only, is an interesting
option in the screening of structure–activity relationships.
The presence of three chlorine atoms makes the cyanuric chlo-
ride (CC, 103) an interesting template for attachment of a chi-
ral auxiliary and for preparing on this way a broad range of
chiral TBCRs (Kamin´ski et al., 1998a, 1999).
Preliminary results have shown that the presence of a chiral
center in TBCR may control activation of the carboxylic func-
tion as well as aminolysis. The symmetrically substituted 2,4,6-
tris(pentaﬂuorophenyloxy)-1,3,5-triazine (TPfT, 117) has been
prepared by reaction of cyanuric chloride (CC, 103) with
potassium pentaﬂuorophenolate in acetonitrile in 67% yield
(Scheme 11), it was shown to be less reactive than pentaﬂuor-
ophenol (Pfp) phosphonium and uronium derivatives (Haber-
mann and Kunz, 1998b).In the search for a fast and efﬁcient coupling procedure pre-
venting undesired side reaction of 4-oxo-1,3-dioxane (118)
(Kamin´ski and Leplawy, 1986) to piperazine (119), (CDMT,
116) in the presence of NMM has been successfully applied
as a condensing reagent.
118       119
NH3
NHO
O
O
O HN
NH
O
O OHThe most often used in peptide synthesis is the monofunc-
tional coupling reagent CDMT (116). The ﬁrst successful
application of CDMT (116) for the preparation of peptides
has remained relatively unknown because of the doubts con-
cerning the mechanism of coupling (Kamin´ski et al., 1983).
(DCMT, 115) is stable, however, only when the reagent has
been highly puriﬁed. The presence of impurities causes its
decomposition (Siegel, 1978). Analogously, the high purity of
the preparation is a necessary requirement for the successful
storage of (CDMT, 116). In the disadvantageous case, the for-
mation of gaseous products may generate a rapid pressure in-
crease in the container, and accordingly, precautions should be
taken to avoid serious risk of blowout of toxic gases. In the
pure state, however, (DCMT, 115) as well as (CDMT, 116)
are stable almost indeﬁnitely (20 years in the author’s labora-
tory) without any traces of decomposition (Kamin´ski, 1996).
The ﬁrst successful isolation of acyloxy-1,3,5-triazines by
Kamin´ski has been performed in experiments involving
chloro-1,3,5-triazines substituted with methoxyl groups
CDMT (116) (Kamin´ski, 1990) and DCMT (115) (Kamin´ski,
1991). 2,4-diacyloxy-6-methoxy-1,3,5-triazines (120) were ob-
tained in 55–99% yield by treating (DCMT, 115) with 2 equiv.
of carboxylic acid in the presence of N-methylmorpholine
(NMM) (Scheme 12).
Recent development in peptide coupling reagents 111Many analogues of (CDMT, 116) (121–129) were obtained
by varying the number and the nature of substituents in the tri-
azine ring. Their utility in condensation reactions has been
conﬁrmed (Kamin´ski, 1996). In most cases, the alteration of
the structure is based on inclusion of modiﬁed alkoxy or aryl-
oxy groups into the triazine ring. All were prepared from cyan-
uric chloride (CC, 103) by stepwise substitution of chlorine
atoms. As a general rule, for the best results it is necessary
to follow the optimal reaction conditions typical for stepwise
substitution. The ﬁrst substituent needs to be introduced at
0–30 C followed by subsequent replacement of the second
chlorine atom under more vigorous conditions, even in the
case of symmetrically disubstituted triazines.N
N
N
Cl
O
121
Cl
N
N
N
Cl
O
122
O
N
N
N
Cl
O
123
O
N
N
N
Cl
O
124
O
ClCl
N
N
N
Cl
O
125
O
N
N
N
Cl
N
126
O
O
O
N
N
N
Cl
O
127
N
128
N
N
N
Cl
O
129
O
N
N
N
Cl
OO
O
O
NO O
O
N
NThe reactivity of triazine in nucleophilic substitutions of
halogen atoms has been studied (Rys et al., 1971; Ostrogovich
et al., 1981; Hunter et al., 1995). The comparison of halogen
susceptibility toward nucleophilic attack shows the order
F > Br > Cl (Kamin´ski, 2000).
Several chiral monochloro- and dichloro-TBCRs (130–134)
have been obtained and applied as enantiodifferentiating cou-
pling reagents (Kamin´ski et al., 1999).
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It is well known that the presence of nucleophilic heteroat-
oms in the substrate may severely deteriorate the course of
coupling reactions. To overcome this barrier, it became neces-sary to introduce protecting groups in order to modify the
reactivity of heteroatoms. Such a strategy is most common
in the cases of nucleophilic amino, hydroxyl and thiol groups.
The fairly well-documented application of (CDMT, 116) in
the synthesis of compounds bearing heteroatoms illustrates
two aspects of TBCRs. On the one hand, these powerful acyl-
ating species are efﬁcient in reactions involving such trouble-
some substrates as tert-butylamine, N-alkylamino acids or
Ca,a disubstituted glycines. On the other hand, there are many
examples demonstrating the surprising selectivity of TBCR in
the synthesis involving substrates with unprotected –NH2 and
–OH groups.
CDMT (116) is a cheap reagent which has been used mainly
in SPPS. In the presence of N-methylmorpholine (NMM) as
base, the reagent gives low levels of racemization (<4.2%).
It has also been used for the coupling of hindered amino acids
(Kamin´ski, 1987, 1994). Treatment of 2-ethylhexanoic acid
with (CDMT, 116) in the presence of a chiral tertiary amine
(strychnine, 135) gave a weakly basic product, which was iso-
lated and identiﬁed (Siegel, 1978; Kamin´ski, 1996) as the ex-
pected triazine ester 136.It has been found that successful activation of carboxylic
acids by means of 2-chloro-4,6-disubstituted-1,3,5-triazines re-
quires the presence of a tertiary amine in the reacting medium.
Generally, this reaction of amine with (CDMT, 116) could be
considered erratic because only a few of all tertiary amines re-
spond to treatment with this reagent.
Moreover, the borderline between reactive amines does not
correlate with the basicity of amines in polar solvents. This
suggests participation of an intermediate, formed in the ﬁrst
step, involving an amine as the obligatory component. Further
studies on the activation of carboxylic acids by means of
(CDMT, 116) conﬁrmed a multistep process proceeding via
triazinylammonium salts, such as 137 and (DMTMM, 138)
formed in situ in the presence of the appropriate amine (Ka-
min´ski et al., 1998a,b; Kamin´ski, 2000).
The rate of formation of triazinylammonium salts 137 and
138 strongly depends on the steric hindrance of N-substituents
(amine). For more hindered amines, rapid loss of reactivity of
116 is observed. Only amines prone to the formation of salts
such as, 137 and 138 when treated with 116 are useful in acti-
vation of the carboxylic function. Triethylamine (Et3N), which
does not form a quarternary ammonium salt at low tempera-
ture in the reaction with (CDMT, 116) was entirely incapable
of activating benzoic acid. Moreover, the addition of a tertiary
amine, which otherwise is inactive toward (CDMT, 116) has a
negligible inﬂuence on the rate of activation of carboxylic
acids. Thus, the addition of N,N-dimethylaniline to NMM
does not accelerate the rate of activation of carboxylic acids
by (CDMT, 116) (Kamin´ski et al., 1998b).
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Undoubtly, the crucial stage in the activation of a carbox-
ylic acid by (CDMT, 116) comprises the two subsequent sub-
stitution reactions in the triazine ring (Fig. 5). The ﬁrst one
(a), which involves substitution of the chlorine atom by amine
leading to quarternary ammonium salt 138 has been found to
be extremely sensitive to steric hindrance of amine substitu-
ents. The second reaction (b), which is exceptionally tolerant
to the steric hindrance of the activated carboxylic acid, in-
volves substitution of an amine leaving group by the carboxyl-
ate ion, affording triazine ‘‘superactive esters’’ 139 (Kamin´ski,
2000).
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Alcoholysis of acyloxy-1,3,5-triazines (139) proceeds much
slower than aminolysis. Usually, activation of serine with an
unprotected side-chain hydroxyl group and subsequent cou-
pling with the amino component leads to efﬁcient formation
of peptide. In a large excess of primary or secondary alcohol, un-
der more vigorous conditions, alcoholysis of 139 takes place
after a few days giving the appropriate esters in 41–92% yield
(Kamin´ska et al., 1999). In order to accelerate the alcoholysis
of 139,MgBr2 orDMAPhas been employed as a transesteriﬁca-
tion catalyst. Another approach to esteriﬁcation of carboxylic
acids has involved 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-meth-
ylmorpholinium chloride (138) used as coupling reagent in the
presence of N-methylmorpholine (Kunishima et al., 1999b).
Application of 2 equiv. of 138 gave esters in 34–99% yield in a
relatively fast reaction without addition of any catalysts. This
discrepancy in the efﬁcacy of procedures postulating essentially
the same reactive intermediates requires some comment. It
seems most probable that exceedingly fast acylation reported
in experiments involving an excess of amine and quarternary tri-
azinium salt 138 (Kunishima et al., 1999b) versus experiments
based on the standard (CDMT, 116) procedure (Kamin´ska
et al., 1999) results probably from a different mechanism oper-
ating in the former case. In the presence of a large excess ofamine, triazine esters 139 disproportionate to corresponding
anhydrides and bis(4,6-di-methoxy-1,3,5-triazin-2-yl)-ether
(140), which remain unreactive under the reaction conditions
described (Kamin´ski et al., 1998b). Moreover, this explains
the need for the 2 equiv. of coupling reagent required for efﬁ-
cient coupling mediated by 138, taking into account that only
half of the acyl groups of anhydride are consumed in the acyla-
tion, but the activation of the other requires the second equiva-
lent of activating reagent.
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140The versatility of (CDMT, 116) has been documented by
the successful synthesis of carotenoid–porphyrin–quinone tri-
ads used in the studies of photoinduced electron transfer pro-
cesses (Kuciauskas et al., 1997).
Numerous oligopeptides of 3-heteroaryloamino-2,3-dehydro-
alanine have been obtained using (CDMT, 116) as the coupling
reagent. Opening of 2-phenyl-4-heteroaryloaminomethylene-
5(4H)-oxazolones with a sodium salt of amino acid gave N-ben-
zoyldipeptides, which were further extended in a stepwise proce-
dure involving (CDMT, 116) as coupling reagent.
The reported yield dramatically depends on the structure of
the heterocyclic moiety (Svete et al., 1997). Unfortunately, no
other concurrent coupling method was used to compare the
efﬁcacy of TBCR with the other reagents and the veriﬁcation
of results is not possible in this case.
Relatively high rates of synthesis, diminished sensitivity to
steric hindrance of substrates, along with convenient monitor-
ing of every synthetic stage supplemented by puriﬁcation of
intermediates (if necessary), make the repetitive synthesis in
solution a valuable tool for large-scale preparation of oligo-
peptides. Recently, the solution methodology has been inten-
sively exploited as a valuable supplementation of the tools of
combinatorial chemistry. This includes solution-phase prepa-
ration of sublibraries as well as its cooperative use in combina-
tion with solid-phase techniques. The hybrid approach, a
combination of solution methodology and synthesis on the so-
lid support, beneﬁts from advantages of both, is, therefore, of
promising utility when approaching new synthetic purposes
(Felix et al., 1998; Flynn et al., 1998; Kim et al., 1998). One
of the restrictions of solution synthesis is the absence of a gen-
eral strategy that allows convenient manipulation with excess
of reagents. Compared to the solid state approach, which as-
sures ﬁltration as a convenient and natural way of removing
excess soluble components, developing repetitive methodology
in solution always requires special care to avoid these limita-
tions. Bearing in mind the weakly basic properties of all tri-
azine derivatives, an advantage is offered of an acidic wash
process for removing both excess of triazine condensing re-
agent, as well as any side triazine products. Accordingly, ef-
forts have been made to elucidate the usefulness of TBCR in
repetitive synthesis in solution.
The classic solution procedure, involving mixed anhydrides,
named REMA (Repetitive Excess Mixed Anhydrides) (Tilak,
1970; van Zon and Bayerman, 1976) while assuring high rates
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Scheme 14 Synthesis of 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-
morpholine (141).
N
N
N
Cl
OMeMeO
N
N
N
OMe
NMeO
OMe
+
Cl-
O N Me
116 (CDMT)                                  138 (DMTMM)
(NMM)
Scheme 13 Synthesis of 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-
methylmorpholinium chloride (DMTMM, 138).
Recent development in peptide coupling reagents 113of coupling and convenient removal of excess of acylating re-
agent, inevitably leads to an ambiguous course of peptide bond
formation due to the presence of two different carbonyl
groups. The analogous procedure of removing excess of acyl-
ating reagent has been found efﬁcient also in the case of pep-
tide synthesis. In all coupling proceeding in THF or DMF,
the ﬁnal product has been isolated by ﬁltration or extraction.
Any further trace of the slightly basic triazine derivatives has
been successfully removed by washing of the ﬁnal product with
diluted acids (Kamin´ski et al., 2005).
By a simple reaction of CDMT (116) with N-methyl-mor-
pholine (NMM), the related triazine, 4-(4,6-dimethoxy-1,3,5-
triazin-2-yl)-4-methylmorpholinium chloride (DMTMM,
138), has been prepared in 79% yield (Scheme 13) (Kamin´ski
et al., 1998b) and used for the synthesis of amides. Reaction
rates in THF are faster than with the CDMT/NMM system
(Kunishima et al., 1999a).
In recent years, DMTMM (138) (Kamin´ski et al., 1998b;
Kunishima et al., 1999a) has come to prominence as an effec-
tive coupling agent, ﬁnding applications in amidation (Kuni-
shima et al., 1999c, 2001; Kjell et al., 2005), esteriﬁcation
(Kunishima et al., 1999c), glycosidation (Paoline et al., 2007;
Tanaka et al., 2008) and phosphonylation (Wozniak et al.,
2007) methodology. However, the utility of DMTMM (138)
as a coupling agent is compromised, especially at large scale,
by its instability in organic solution as it undergoes self-imm-
olative degradation, yielding 4-(4,6-dimethoxy-1,3,5-triazin-2-
yl)-4-morpholine (141) and chloromethane (Scheme 14). In
chloroform at ambient temperature, this results in complete
degradation in just 3 h (Kunishima et al., 1999c) (97% degra-
dation is observed in 2 h) (Steven, 2009).
Recently a new generation of triazine-based coupling re-
agents (TBCRs) (Kamin´ski, 1985, 1987, 2000), designed
according to the concept of ‘‘superactive esters’’ (Kamin´ski,
1994), was obtained by treatment of (DMTMM, 138) with lith-
ium or silver tetraﬂuoroborate. To demonstrate the efﬁcacy of
the modiﬁed triazine reagents, with improved stability due to
the use of non-nucleophilic tetraﬂuoroborate counterion, in a
very broad range of typical synthetic applications. The ideaof acceleration of the coupling process in the case of ‘‘superac-
tive esters’’ is based on facile departure of the leaving group by
its rearrangement in energetically favored, consecutive process
to a stable, chemically inert, and neutral side product. This
general approach for designing coupling reagents can be con-
sidered as a valuable alternative, which eliminates the over
activation of acylating intermediate. The new coupling re-
agents are highly versatile in ester and peptide synthesis in
solution as well as in the solid phase. Their application in
the synthesis gave very regular coupling results for the whole
range of amino acids substrates derived from natural and
un-natural sterically hindered amino acids and substantially
reduced amount of side products under broad range of reac-
tion conditions (Kamin´ski et al., 2005).
The 1,3,5-triazinylmethylmorpholinium chloride DMTMM
(138) is an efﬁcient condensing agent which leads to the forma-
tion of esters in the presence of NMM (Kunishima et al.,
1999a,b) e.g. 2-acyloxy-1,3,5-triazines (142) (Farloni et al.,
1999a) and 143 (Farloni et al., 1999b).
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Previous studies proved the participation of 2-acyloxy-
1,3,5-triazines (142) (Kamin´ski, 1990; Sochacki and Kamin´ski,
1994) as powerful acylating intermediates in condensations
involving TBCRs. In fact, triazine esters 142 have already been
found more reactive than any other acylating reagent, includ-
ing N-hydroxybenzotriazole esters (Go´wka et al., 1990). While
esters derived from 1-oxo-2-hydroxydihydrobenzotriazine
(HODhbt, 11) gave better coupling rates than when used as
additive. They have been employed in solid-phase peptide syn-
thesis of the corresponding Fmoc-protected amino acids and
they show a good resistance to racemization (Atherton et al.,
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